Experimental Models in Parkinson’s Disease: Advantages and Disadvantages
Öznur Altunlu(Atatürk University), Ahmet Hacımüftüoğlu(Department of Medical Sciences), Irmak Ferah Okkay(Atatürk University), Ufuk Okkay(Atatürk University), Feyza Burul(Ağrı İbrahim Çeçen University), Esma Topatan(Atatürk University), Selma Sezen(Ağrı İbrahim Çeçen University), Ziadoon Al-yaqoobi(Atatürk University), Cemil Bayram(Atatürk University)
Cited by 5
Related Papers
Sildenafil treatment attenuates lung and kidney injury due to overproduction of oxidant activity in a rat model of sepsis: a biochemical and histopathological study
|Clinical & Experimental Immunology|2011|86
Syringic acid protects against thioacetamide-induced hepatic encephalopathy: Behavioral, biochemical, and molecular evidence
|Neuroscience Letters|2021|45
Hepatoprotective and neuroprotective effect of taxifolin on hepatic encephalopathy in rats
|Metabolic Brain Disease|2022|38
The role of carnitine on ovariectomy and inflammation-induced osteoporosis in rats
|Experimental Biology and Medicine|2013|34
Neuroprotective effect of bromelain in 6-hydroxydopamine induced in vitro model of Parkinson’s disease
|Molecular Biology Reports|2021|32